recordings | CNS National Neurology Grand Rounds

2024-2025 Grand Rounds Series | CNS

Cerebral Venous Thrombosis: An Update

Presenter: Dr. Thalia Field

Original air date: May 2, 2025  Running time: 1 hour

Learning Objectives:

  • Review recent research relating to the epidemiology, pathophysiology, management and prognosis of cerebral venous thrombosis
  • Review persisting uncertainties and directions for future research
  • Discuss clinical management and current guidelines in the context of current knowledge, and knowledge gaps

Modernizing Migraine Care: Insights from the New CHS Guidelines, CGRP Advances, and Emerging Therapies

Presenter: Dr. Lik Hang Tommy Chan

Original air date: March 7, 2025  Running time: 1 hour

Learning Objectives:

  • Review key recommendations from the updated CHS guidelines and their application in the management of migraine, including CGRP-targeted therapies.
  • Highlight strategies for combining preventive and acute therapies, such as CGRP monoclonal antibodies, gepants, and neuromodulation, to enhance patient outcomes.
  • Discuss the role of PACAP-targeted therapies in addressing unmet needs in migraine treatment.

 

Changing Diagnostic and Treatment Paradigms in Multiple Sclerosis 

Presenter: Dr. Jiwon Oh, Medical Director, BARLO Multiple Sclerosis Program, St. Michael's Hospital, Toronto

Original air date: January 31, 2025  Running time: 1 hour

Learning Objectives:

  • To discuss changes in MS diagnosis, treatment initiation, and treatment optimization that have improved clinical outcomes in the past three decades
  • To discuss upcoming changes to the MS diagnostic criteria
  • To discuss emerging biomarkers that may become incorporated in clinical practice in the near future to further improve clinical outcomes in people with MS

 

Emerging Disease Modifying Therapies for Alzheimer Disease

Presenter: Dr. Howard Chertkow

Original air date: October 18, 2024  Running time: 1 hour

  • To understand the impact of coming anti-amyloid disease modifying therapies for AD
  • To appreciate other mechanisms of disease modification we will see in the future.